The authors of An additional paper reported the administration of HBOT as adjuvant therapy for acute macular neuroretinopathy in systemic lupus erythematosus in conjunction with immunosuppression in two patients [11].Youn et al. [54] highlighted The shortage of consensus in managing CRAO via a countrywide study in The us. The research surveyed dire